Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019:

Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future

Report Code: PHM223A

Publish Date: Jan 2020

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.

Report Includes

  • An overview of top five opportunities for generic or biosimilar drugs in pharmaceuticals market 2019
  • Coverage of generics and discussion on their characteristics
  • Information on Hatchmann-Wax act and its effect on market competitiveness impacting pricing and development of original drugs
  • Insights on the key challenges and opportunities in the development of generics or biosimilar drugs
  • Description of product class, mechanism of action, indications and contraindications,
  • clinical and generic development of the prominent products
  • Detailed patent analysis i.e. expiry and exclusivity, regulations and policies and patent expiry and market impact
  • Profiles of key competitors engaged in the development of generic and biosimilars

 

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future74Free

Related Reports

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 12

  • Table 1: List of Biosimilars Produced in E. Coli
  • Table 2: List of Biosimilars Produced in Mammalian Cells
  • Table 3: Number of Approved Biosimilars, by Type
  • Table 4: Generics vs. Biosimilars
  • Table 5: List of Key Products
  • Table 6: Sales of Xolair, Through 2018
  • Table 7: Approved Indications for Use of Revlimid
  • Table 8: Sales of Revlimid, Through 2018
  • Table 9: Dosage Recommendation Per Patient Weight
  • Table 10: Sales of Orencia, Through 2018
  • Table 11: Sales of Pradaxa, Through 2018
Sample Report

Recent Reports

Brain Tumor Therapeutics: Global Markets to 2030

Published - Oct 2025 | Publisher - BCC Publishing | Code - PHM208B

The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.

Global Viral Vector Manufacturing Markets and Technologies Through 2030

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM172B

The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.

Hyaluronic Acid in Healthcare: Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM284A

The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.

Targeted Alpha Therapies for Cancer Treatment: Global Market

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM287A

This report provides an overview of the global market for targeted alpha therapies for cancer and analyses market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM072B

The global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future
Customize Report
AI: Your Say